Zenterio has accepted an offer on its quality assurance and testing company Labatus from Eurofins Scientific
Stockholm, 25 July 2016 – Zenterio, a leading TV technology and services provider today announces the sale of its quality assurance and testing company Labatus to Eurofins Scientific.
Labatus, based in Linköping, has been a part of Zenterios since September 2014, when it was acquired as a part the 27M Group. Labatus has been a valuable part of Zenterio and, as it has been run as a separate entity, a close partner on a number of projects. Labatus had a total revenue of 23 MSEK and an operating profit of 2,7 MSEK in 2015, with an average number of 20 employees.
Jorgen Nilsson, CEO, Zenterio, said: “As Zenterio aim to fuel innovation and create independence for operators, we feel that there is a need to separate the quality assurance and testing from Zenterio itself. Labatus is a successful company in its own right, and having an outside testing lab will only work to strengthen the quality of our products and services, as well as Labatus independence. Aside from the commercial aspects of the sale, we believe that it will be something that all parties benefit from, allowing Labatus expertise to be used to its full extent and Eurofins to establish a strong presence in the Nordic region.”
The two companies will continue its strong partnership and will work closely together on current and future projects.
For more information, please contact:
Jörgen Nilsson, CEO
Phone: +46 13 36 39 50
Zenterio provides an independent OS for interactive TV aimed at creating an industry standard. Zenterio also offers an intuitive multiscreen UI, a powerful Data Analytics solution, Consulting Services and additional Value Added Services to TV operators. Zenterio partners with global system integrators, set-top box suppliers, CA/DRM providers, chipset manufacturers and services providers. Zenterio has offices in Stockholm, Linköping and Atlanta and is owned by private investors and private equity firm Scope. The Chairman of the Board is former Nokia CEO Mr. Olli-Pekka Kallasvuo and the CEO is former Ericsson executive Mr. Jorgen Nilsson. For more information please visit zenterio.com.
Eurofins Scientific believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With over 23,000 staff in more than 225 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities and healthcare practitioners around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).